Allogeneic transplant following CAR T-cell therapy for large B-cell lymphomaJoanna Zurko, Alex F. Herrera, Adam S. Kittai et al.|Haematologica|2022Cited by 73
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndromeAdam S. Kittai, Samantha Jaglowski, David A. Bond et al.|Blood Advances|2020Cited by 70
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research RegistryRachel Cusatis, Bronwen E. Shaw, Carlos Litovich et al.|Transplantation and Cellular Therapy|2024Cited by 68
A phase Ib/II study evaluating activity and tolerability of BTK inhibitor PCI-32765 and ofatumumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and related diseases.Samantha Jaglowski, John C. Byrd, Jeffrey A. Jones et al.|Journal of Clinical Oncology|2012Cited by 65
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter AnalysisAdam S. Kittai, Alexey V. Danilov, Ying Huang et al.|Transplantation and Cellular Therapy|2020Cited by 60